A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)

NCT01801397 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Low Bone Mass in Anorexia Nervosa Patients

Interventions

DRUG: osteoanabolic therapy

Sponsor

University of Zurich